Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Crossbow Therapeutics logo

Crossbow Therapeutics

Recent Finacing

Series B

Recent Raise

$77M

Crossbow Therapeutics is a biotechnology company developing TCR-mimetic (T-Bolt™) antibody T-cell engager therapies that target peptide–HLA complexes on cancer cells.

Founded 2021
Massachusetts, United States
11-50
Private
crossbowtx.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Life Science
Medical
Oncology

Recent Investors

BVF Partners logo
Pfizer Ventures logo
Mirae Asset Venture Investment logo
Polaris Partners logo
Eli Lilly and Company logo
MPM Capital logo
Mirae Asset Capital logo
A
Sixty Degree Capital logo
Taiho Ventures logo
The Leukemia & Lymphoma Society logo
LifeLink logo

Financials

$157M

Total Raised

2

Funding rounds

7

Investors


Team

Upgrade to view the team

See the team members at Crossbow Therapeutics.